name: | Delafloxacin_1 |
ATC code: | J01MA23_1 | route: | oral |
n-compartments | 2 |
Delafloxacin is a fluoroquinolone antibiotic approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and community-acquired bacterial pneumonia (CABP) in adults. It is active against a broad range of Gram-positive and Gram-negative bacteria, including MRSA.
Population pharmacokinetic model for healthy adult subjects and patients, both male and female, aged 18–85 years; values representative for a single 450 mg oral dose, fasted.